Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 113

1.

Implications of pharmacogenetic testing for patients taking warfarin or clopidogrel.

Donohue MM, Tirschwell DL.

Curr Neurol Neurosci Rep. 2011 Feb;11(1):52-60. doi: 10.1007/s11910-010-0157-8. Review.

PMID:
21046289
2.

The role of warfarin and aspirin in secondary prevention of stroke.

Elkind MS.

Curr Cardiol Rep. 2004 Mar;6(2):135-42. Review.

PMID:
14759359
3.

Pharmacogenetics of antiplatelets and anticoagulants: a report on clopidogrel, warfarin and dabigatran.

Ross S, Paré G.

Pharmacogenomics. 2013 Oct;14(13):1565-72. doi: 10.2217/pgs.13.149. Review.

PMID:
24088127
4.

Recent developments in clopidogrel pharmacology and their relation to clinical outcomes.

Gurbel PA, Antonino MJ, Tantry US.

Expert Opin Drug Metab Toxicol. 2009 Aug;5(8):989-1004. doi: 10.1517/17425250903107772. Review.

PMID:
19575629
5.

Pharmacogenetics testing: implications for cardiovascular therapeutics with clopidogrel and warfarin.

George J, Doney A, Palmer CN, Lang CC.

Cardiovasc Ther. 2010 Jun;28(3):135-8. doi: 10.1111/j.1755-5922.2010.00176.x. No abstract available.

PMID:
20557312
6.

Prevention of stroke in patients with atrial fibrillation.

[No authors listed]

Med Lett Drugs Ther. 2009 Jun 1;51(1313):41. No abstract available.

PMID:
19478692
7.

Clopidogrel pharmacogenetics and its clinical implications.

Singh M, Thapa B, Arora R.

Am J Ther. 2010 May-Jun;17(3):e66-73. doi: 10.1097/MJT.0b013e3181afbf62. Review.

PMID:
19636246
8.

Contribution of gene sequence variations of the hepatic cytochrome P450 3A4 enzyme to variability in individual responsiveness to clopidogrel.

Angiolillo DJ, Fernandez-Ortiz A, Bernardo E, Ramírez C, Cavallari U, Trabetti E, Sabaté M, Hernández R, Moreno R, Escaned J, Alfonso F, Bañuelos C, Costa MA, Bass TA, Pignatti PF, Macaya C.

Arterioscler Thromb Vasc Biol. 2006 Aug;26(8):1895-900. Epub 2006 Apr 27.

9.

Choices in medical management for prevention of acute ischemic stroke.

Fleck JD, Biller J.

Curr Neurol Neurosci Rep. 2001 Jan;1(1):33-8. Review.

PMID:
11898498
10.

Aspirin, clopidogrel, and warfarin: is the combination appropriate and effective or inappropriate and too dangerous?

Hermosillo AJ, Spinler SA.

Ann Pharmacother. 2008 Jun;42(6):790-805. doi: 10.1345/aph.1K591. Epub 2008 May 13. Review. Erratum in: Ann Pharmacother. 2008 Oct;42(10):1521.

PMID:
18477734
11.

Drug evaluation of clopidogrel in patients with ischemic stroke.

Hassan AE, Zacharatos H, Suri MF, Qureshi AI.

Expert Opin Pharmacother. 2007 Nov;8(16):2825-38. Review.

PMID:
17956202
12.

New possibilities in anticoagulant management of atrial fibrillation.

Waldo AL.

Rev Cardiovasc Med. 2004;5 Suppl 5:S30-8. Review.

PMID:
15619613
13.

Outcomes related to antiplatelet or anticoagulation use in patients undergoing carotid endarterectomy.

Rosenbaum A, Rizvi AZ, Alden PB, Tretinyak AS, Graber JN, Goldman JA, Sullivan TM.

Ann Vasc Surg. 2011 Jan;25(1):25-31. doi: 10.1016/j.avsg.2010.06.007.

PMID:
20889291
14.

Warfarin versus aspirin in the secondary prevention of stroke: the WARSS study.

Redman AR, Allen LC.

Curr Atheroscler Rep. 2002 Jul;4(4):319-25. Review.

PMID:
12052284
15.

Pharmacogenetics of neural injury recovery.

Pearson-Fuhrhop KM, Cramer SC.

Pharmacogenomics. 2013 Oct;14(13):1635-43. doi: 10.2217/pgs.13.152.

PMID:
24088134
16.

The use of antithrombotic drugs in older people.

Tufano A, Cerbone AM, Di Minno G.

Minerva Med. 2002 Feb;93(1):13-26. Review.

PMID:
11850611
17.

Safety and efficacy of aspirin, clopidogrel, and warfarin after coronary stent placement in patients with an indication for anticoagulation.

Orford JL, Fasseas P, Melby S, Burger K, Steinhubl SR, Holmes DR, Berger PB.

Am Heart J. 2004 Mar;147(3):463-7.

PMID:
14999195
19.

Stroke prevention in patients with atrial fibrillation.

Ono A, Fujita T.

J Clin Neurosci. 2003 Jan;10(1):71-3.

PMID:
12464526
20.

A comparison of warfarin and aspirin for the prevention of recurrent ischemic stroke.

Mohr JP, Thompson JL, Lazar RM, Levin B, Sacco RL, Furie KL, Kistler JP, Albers GW, Pettigrew LC, Adams HP Jr, Jackson CM, Pullicino P; Warfarin-Aspirin Recurrent Stroke Study Group..

N Engl J Med. 2001 Nov 15;345(20):1444-51.

Supplemental Content

Support Center